Oak J N, Oldenhof J, Van Tol H H
Laboratory of Molecular Neurobiology, Centre for Addiction and Mental Health, Clarke Div., 250 College street, M5T 1R8, Toronto, Ontario, Canada.
Eur J Pharmacol. 2000 Sep 29;405(1-3):303-27. doi: 10.1016/s0014-2999(00)00562-8.
Dopamine is an important neurotransmitter involved in motor control, endocrine function, reward, cognition and emotion. Dopamine receptors belong to the superfamily of G protein-coupled receptors and play a crucial role in mediating the diverse effects of dopamine in the central nervous system (CNS). The dopaminergic system is implicated in disorders such as Parkinson's disease and addiction, and is the major target for antipsychotic medication in the treatment of schizophrenia. Molecular cloning studies a decade ago revealed the existence of five different dopamine receptor subtypes in mammalian species. While the presence of the abundantly expressed dopamine D(1) and D(2) receptors was predicted from biochemical and pharmacological work, the cloning of the less abundant dopamine D(3), D(4) and D(5) receptors was not anticipated. The identification of these novel dopamine receptor family members posed a challenge with respect to determining their precise physiological roles and identifying their potential as therapeutic targets for dopamine-related disorders. This review is focused on the accomplishments of one decade of research on the dopamine D(4) receptor. New insights into the biochemistry of the dopamine D(4) receptor include the discovery that this G protein-coupled receptor can directly interact with SH3 domains. At the physiological level, converging evidence from transgenic mouse work and human genetic studies suggests that this receptor has a role in exploratory behavior and as a genetic susceptibility factor for attention deficit hyperactivity disorder.
多巴胺是一种重要的神经递质,参与运动控制、内分泌功能、奖赏、认知和情感等过程。多巴胺受体属于G蛋白偶联受体超家族,在介导多巴胺在中枢神经系统(CNS)中的多种作用方面发挥着关键作用。多巴胺能系统与帕金森病和成瘾等疾病有关,并且是治疗精神分裂症的抗精神病药物的主要靶点。十年前的分子克隆研究揭示了哺乳动物物种中存在五种不同的多巴胺受体亚型。虽然根据生化和药理学研究预测了大量表达的多巴胺D(1)和D(2)受体的存在,但较少表达的多巴胺D(3)、D(4)和D(5)受体的克隆却出乎意料。这些新型多巴胺受体家族成员的鉴定在确定其精确的生理作用以及确定它们作为多巴胺相关疾病治疗靶点的潜力方面提出了挑战。本综述聚焦于对多巴胺D(4)受体十年研究的成果。对多巴胺D(4)受体生物化学的新见解包括发现这种G蛋白偶联受体可直接与SH3结构域相互作用。在生理水平上,来自转基因小鼠研究和人类遗传学研究的越来越多的证据表明,该受体在探索行为中起作用,并且是注意缺陷多动障碍的遗传易感性因素。